FASLG and viral infectious disease: Therefore, targeting FasL is not expected to negatively impact T cell activation as shown by efficient clearance of acute viral infections by Fas and FasL-deficient mutant mice (Hughes et al., 2008; Hutcheson et al., 2008; Weant et al., 2008).